MTOR and cancer: The dual inhibitor, BEZ235 can inhibit not only the over-expressed PI3K/Akt/mTOR signalling pathway in colon cancer cells but also the PD-L1 expression, the later can then increase the sensitivity of cancer cells to T cell-mediated killing.